Results 251 to 260 of about 31,835 (290)
Some of the next articles are maybe not open access.

Hepatic endometrial stromal sarcoma

Pathology - Research and Practice, 2018
Endometrial stromal sarcomas are rare tumors that may recur or metastasize many years after their initial presentation. Though most recurrences are within the pelvis, distant metastases can occur, and are most common to the lungs. Metastases to the liver are extremely rare.
Rajni Chibbar   +4 more
openaire   +3 more sources

A novel MBTD1‐PHF1 gene fusion in endometrial stromal sarcoma: A case report and literature review

Genes, Chromosomes and Cancer, 2020
The classification of endometrial stromal sarcoma (ESS) has been refined and aided by the discovery of various recurrent gene translocations. Low‐grade ESS (LG‐ESS) is most commonly characterized by JAZF1‐SUZ12 fusions followed by rearrangements ...
Lisa Han   +3 more
semanticscholar   +1 more source

Low-Grade Endometrial Stromal Sarcoma [PDF]

open access: yesSoft Tissue Tumors, 2020
Low-grade endometrial stromal sarcoma is a uterine sarcoma arising from the endometrial stroma.
S. Mocellin
semanticscholar   +4 more sources

Endometrial stromal sarcoma of the uterus

Anti-Cancer Drugs, 1991
Uterine sarcomas are rare tumors constituting 1-3% of all uterine malignancies. These tumors are characterized by aggressive growth and by poor overall prognosis. There is much controversy concerning diagnostic criteria and the great variation in histology, as well as the role of radiotherapy and chemotherapy in the management of these tumors.
Harald Meden   +3 more
openaire   +3 more sources

Collision Tumor of Endometrial Large Cell Neuroendocrine Carcinoma and Low-Grade Endometrial Stromal Sarcoma: A Case Report and Review of the Literature

International Journal of Surgical Pathology, 2020
Large cell neuroendocrine carcinoma (LCNEC) of the endometrium is an exceedingly rare histologic subtype of endometrial cancer (0.8%). These tumors are highly aggressive with a propensity for metastasis and have a poor prognosis.
G. Rivera   +4 more
semanticscholar   +1 more source

Metastatic low‐grade endometrial stromal sarcoma after 24 years: A case report and review of recent molecular genetics

Diagnostic Cytopathology, 2020
Low‐grade endometrial stromal sarcoma (LGESS) is a rare malignant uterine tumor with the potential to metastasize years after the primary resection. There is a broad differential diagnosis for endometrial stromal sarcomas (ESS), including both benign and
Andres E Mindiola-Romero   +6 more
semanticscholar   +1 more source

Endometrial Stromal Sarcoma

Obstetrics & Gynecology, 2013
To summarize available studies with respect to evaluation and management of patients with endometrial stromal sarcoma and undifferentiated endometrial sarcoma.We conducted an electronic search of research articles published in English between January 1, 1981, and January 1, 2013, using MEDLINE, PubMed, and ClinicalTrials.gov (www.clinicaltrials.gov ...
Marcela G. del Carmen   +1 more
openaire   +2 more sources

Right heart masses in a patient with endometrial stromal sarcoma

Journal of Clinical Ultrasound, 2020
We present the case of a 61‐year‐old woman with a large tumoral infiltration extending from the pelvis throughout the inferior vena cava inferior to the right atrium, protruding into the right ventricle and right ventricular outflow tract.
M. Tadic   +4 more
semanticscholar   +1 more source

Endometrial stromal sarcoma: A review of rare mesenchymal uterine neoplasm

The journal of obstetrics and gynaecology research, 2020
This review aims to analyze the pathological aspects, diagnosis and treatment of rare mesenchymal uterine tumors.
V. Capozzi   +6 more
semanticscholar   +1 more source

Endometrial Stromal Sarcoma in the Young

Journal of Clinical Gynecology and Obstetrics, 2020
Endometrial stromal sarcoma (ESS) represents a very rare group of malignant tumors comprising less than 10% of all uterine sarcomas but only around 0.2% of all uterine cancer. In developing countries, the prevalence of ESS is approximately two in a million perimenopausal women between ages of 45 and 50 years. The occurrence in younger women is rare and
Mikaela Erlinda Germar Martinez   +1 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy